TNF Inhibitor denied due to quantity / dose limits by Humana?

Humana's specific coverage criteria for tnf inhibitor are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Limits Quantity for TNF Inhibitors — and Why You Can Appeal

TNF inhibitors are dispensed as prefilled syringes, autoinjectors, or infusion vials on scheduled intervals that vary by drug and indication. Humana applies quantity limits to these medications to align dispensing amounts with what it considers standard administration schedules. A quantity-limit denial means your pharmacy claim exceeded the units Humana permits per fill cycle or per defined period. This may occur if your prescriber has recommended a dosing schedule that differs from Humana's administrative default, or if there was a data-entry discrepancy in the original claim.

## Why This Is Appealable

Quantity limits are administrative policy defaults — they are not individualized clinical determinations. When your prescriber has a medical reason to prescribe a quantity or interval that differs from Humana's limit, you are entitled to request an exception. Under ACA §2719 and ERISA §503, you have the right to a full-and-fair internal review by a clinical peer and, if that is denied, an independent external review by a certified IRO. The external review window is generally within approximately four months of denial. An expedited review option is available when standard timing would seriously jeopardize your health.

## The Appeal Process and Timeline

1. Request the denial letter and Humana's quantity-limit policy: confirm the exact limit applied and the policy basis. 2. Confirm the prescription against the FDA label: verify with your prescriber that the prescribed quantity aligns with an approved dosing regimen on the current prescribing label. 3. File an internal appeal or exception request: observe the deadline in your denial letter. Many quantity-limit appeals can be resolved at this stage with a short prescriber justification. 4. Escalate to external review if the internal appeal is upheld. 5. Expedited track: available when clinically urgent.

## Documentation to Gather

• Prescriber justification letter: your physician should explain the prescribed quantity and dosing schedule, cite the FDA-approved dosing range from the label, and state the clinical rationale for the specific regimen ordered.
• FDA-approved prescribing label: obtain the current label and confirm which dosing regimens are approved — your prescribed quantity should correspond to a label-supported schedule.
• Diagnosis and clinical documentation: chart notes confirming the indication and disease course.
• Prior treatment history (if relevant): if a dose adjustment was made in response to inadequate response or relapse, document the clinical basis for that change.
• Humana's quantity-limit policy: request this document and identify the specific limit and any exception criteria.

## Criteria-Mapping Structure

| Humana Quantity-Limit Criterion | Your Response | |---|---| | Quantity within approved labeling | [FDA label dosing range; prescriber confirmation] | | Medical justification for prescribed quantity | [Prescriber letter with clinical rationale] | | Diagnosis and indication | [Chart documentation] |

Quantity-limit denials are among the more straightforward to appeal when the prescribed quantity is grounded in the FDA-approved label and the prescriber provides a brief, specific justification.